cannabis indica

Hipertensão Arterial

termo de indexação original: Hypertension (High Blood Pressure)

O acervo do Cannabis Indica reúne 125 estudos científicos que tocam a condição Hipertensão Arterial, publicados entre 1977 e 2024. Pela leitura automatizada, 86 (69%) foram classificados como favoráveis, 14 (11%) como inconclusivos e 25 (20%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (49 estudos), seguido de estudo em animais (31). Os compostos mais presentes são Anandamida (AEA), Hidrolase de Amidas de Ácidos Graxos (FAAH) e 2-Araquidonoilglicerol (2-AG). Aparece com frequência ao lado de Doenças Cardiovasculares (DCV), Inflamação e Dor.

Estudos indexados
125
Período coberto
1977–2024
Favoráveis
86 · 69%
Inconclusivos
14 · 11%
Desfavoráveis
25 · 20%
Termo original
Hypertension (High Blood Pressure)

O acervo em números

Tipo de estudo

Metanálise49
Estudo em Animais31
Ensaio Clínico23
Ensaio Clínico Duplo-Cego16
Estudo Laboratorial5
Metanálise Clínica1

Direção do resultado

Favorável86
Inconclusivo14
Desfavorável25

Por década

1970s3
1980s1
1990s2
2000s14
2010s37
2020s68

125 estudos

Filtrar e buscar no acervo →
  1. 2024

    Effects of Chronic Cannabidiol Dosing on Brain Blood Flow: Insights from the Hyper-H21-4 Trial

    InconclusivoEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)
  2. 2023

    A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+7
  3. 2023

    Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report

    FavorávelMetanáliseDorInflamaçãoAnsiedade+3
  4. 2023

    CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Anandamida (AEA)2-Araquidonoilglicerol (2-AG)
  5. 2023

    Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover Study

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)
  6. 2023

    Cocaine-Induced Raynaud's Phenomenon: A Case Report

  7. 2023

    Exploring the Neuroprotective Effects of Spirulina platensis: Insights Into Hemorrhagic Volume and Histological Outcomes

  8. 2023

    Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 Inhibitors

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+2
  9. 2023

    Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest

  10. 2023

    The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Insônia e Distúrbios do Sono
  11. 2023

    Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study

  12. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  13. 2022

    Acute and long-term effects of cannabinoids on hypertension and kidney injury

    DesfavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Doença Renal CrônicaAnandamida (AEA)
  14. 2022

    Acute Cannabigerol Administration Lowers Blood Pressure in Mice

  15. 2022

    Acute pancreatitis as a rare adverse event among cannabis users: A systematic review

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisAnandamida (AEA)+16
  16. 2022

    Adolescent e-cigarette or vaping product use-associated lung injury: A case series and review of the literature

    DesfavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Asma+3
  17. 2022

    Advanced Meditation and Vegan Diet Increased Acylglycines and Reduced Lipids Associated with Improved Health: A Prospective Longitudinal Study

  18. 2022

    Borneol reduces sympathetic vasomotor hyperactivity and restores depressed baroreflex sensitivity in rats with renovascular hypertension

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  19. 2022

    Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection

  20. 2022

    Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)

  21. 2022

    Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing

  22. 2022

    CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review

  23. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+7
  24. 2022

    Drugs of Misuse: Focus on Vascular Dysfunction

  25. 2022

    E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

    DesfavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+16
  26. 2022

    GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries

  27. 2022

    Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults

  28. 2022

    Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

  29. 2022

    Marijuana-induced myocarditis in a 24-year-old man

  30. 2022

    Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

  31. 2022

    Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study

  32. 2022

    Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States

    DesfavorávelMetanáliseDependência QuímicaInflamaçãoEfeitos Adversos da Cannabis+8
  33. 2022

    Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial

  34. 2022

    Pharmacological effects of cannabidiol by transient receptor potential channels

    FavorávelMetanáliseDorCâncerInflamação+5
  35. 2022

    Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)EpilepsiaPsicoseAyahuasca+6
  36. 2022

    The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+7
  37. 2022

    The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders

  38. 2022

    The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Doença Renal CrônicaFicocianina
  39. 2022

    Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

    FavorávelEstudo em AnimaisDorCâncerInflamação+16
  40. 2021

    A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

  41. 2021

    A study of abnormal cannabidiols system-mediated cardiovascular protection in disrupted gut/brain axis associated depression

  42. 2021

    Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

    FavorávelMetanáliseDorDependência QuímicaInflamação+7
  43. 2021

    Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study

  44. 2021

    At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk

  45. 2021

    Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report

  46. 2021

    Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome

  47. 2021

    Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  48. 2021

    Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension

  49. 2021

    Cannabis is associated with blood pressure reduction in older adults - A 24-hours ambulatory blood pressure monitoring study

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)
  50. 2021

    Cannabis sativa Linnaeus as traditional phytomedicine by folk medicine practitioners of Bangladesh

  51. 2021

    Cannabis sativa subsp. sativa's pharmacological properties and health effects: A scoping review of current evidence

    FavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Diabetes+5
  52. 2021

    Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)
  53. 2021

    COVID-19 and Cannabis: Playing Saint or Devil?

  54. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  55. 2021

    The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects

    FavorávelEnsaio Clínico Duplo-CegoDorDoenças Cardiovasculares (DCV)GlaucomaTHC Farmacêutico+1
  56. 2021

    The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome

  57. 2021

    The longitudinal relationship between cannabis use and hypertension

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)
  58. 2020

    A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)
  59. 2020

    Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)

  60. 2020

    Cannabinoid Type 2 Receptor Agonist JWH133 Decreases Blood Pressure of Spontaneously Hypertensive Rats Through Relieving Inflammation in the Rostral Ventrolateral Medulla of the Brain

  61. 2020

    Capsaicin Causes Vasorelaxation of Rat Aorta through Blocking of L-type Ca2+ Channels and Activation of CB1 Receptors

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Capsaicina (CAPS)
  62. 2020

    Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats With Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism

  63. 2020

    Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature

  64. 2020

    Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats

  65. 2020

    Stimulation of Atypical Cannabinoid Receptor GPR55 Abolishes the Symptoms of Detrusor Overactivity in Spontaneously Hypertensive Rats

  66. 2020

    Stimulation of Brain Cannabinoid CB 1 Receptors Can Ameliorate Hypertension in Spontaneously Hypertensive Rats

  67. 2020

    The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)
  68. 2020

    Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoArritmias Cardíacas+3
  69. 2019

    Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  70. 2019

    Cannabinoid-sensitive receptors in cardiac physiology and ischaemia

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoAterosclerose+1
  71. 2019

    Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)CBD Farmacêutico
  72. 2019

    The Endocannabinoid System of Animals

  73. 2019

    US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+16
  74. 2018

    A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)Tetraidrocanabinol (THC)
  75. 2018

    Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)ObesidadeDiabetesEndocanabinoide (não especificado)+1
  76. 2018

    The Endocannabinoid System Affects Myocardial Glucose Metabolism in the DOCA-Salt Model of Hypertension.

  77. 2018

    Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies

  78. 2017

    A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)
  79. 2017

    Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure

  80. 2017

    Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial

  81. 2016

    A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Síndrome Metabólica
  82. 2016

    Anandamide and its metabolites: what are their roles in the kidney?

  83. 2016

    Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

  84. 2016

    Geraniol Improves Endothelial Function by Inhibiting NOX-2 Derived Oxidative Stress in High Fat Diet Fed Mice

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Estresse OxidativoAterosclerose
  85. 2016

    Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  86. 2016

    Lysophosphatidylinositol Signalling and Metabolic Diseases

  87. 2016

    Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters

  88. 2015

    Clinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis: Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet Activation

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaFicocianina+4
  89. 2014

    A Novel Hemp Seed Meal Protein Hydrolysate Reduces Oxidative Stress Factors in Spontaneously Hypertensive Rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Estresse Oxidativo
  90. 2013

    Addition of capsaicin and exchange of carbohydrate with protein counteract energy intake restriction effects on fullness and energy expenditure

  91. 2013

    Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Diabetes
  92. 2013

    Cardiovascular effects induced by α-terpineol in hypertensive rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Estresse Oxidativo
  93. 2013

    Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study

  94. 2012

    Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans

  95. 2012

    Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

  96. 2012

    Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.

  97. 2012

    L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease

  98. 2012

    Renoprotective and antioxidant effects of cilnidipine in hypertensive patients

  99. 2012

    Role of arachidonoylethanolamine in blood pressure regulation in volume-resistant patients on peritoneal dialysis.

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)HemodiáliseAnandamida (AEA)
  100. 2011

    Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria

  101. 2011

    Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress.

  102. 2011

    Increased blood pressure after abrupt cessation of daily cannabis use

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)
  103. 2011

    Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  104. 2011

    Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients

  105. 2010

    Clinical and Experimental Pharmacology and Physiology Clinical and Experimental Pharmacology and Physiology Free Access Unravelling the cardiovascular effects induced by α-terpineol: A role for the nitric oxide–cGMP pathway

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)
  106. 2009

    Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.

  107. 2009

    Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

  108. 2008

    Targeting the endocannabinoid system: to enhance or reduce?

  109. 2008

    Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product

  110. 2007

    Cannabinoids and cardiovascular disease: the outlook for clinical treatments.

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)
  111. 2006

    Chirality Influences the Effects of Linalool on Physiological Parameters of Stress

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)
  112. 2006

    Dronabinol Reduces Signs And Symptoms Of Idiopathic Intracranial Hypertension: A Case Report.

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)EnxaquecaTHC Farmacêutico
  113. 2006

    Olfactory stimulation with scent of lavender oil affects autonomic neurotransmission and blood pressure in rats.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  114. 2005

    Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta

  115. 2004

    Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition.

  116. 2004

    Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)N-Araquidonoil Dopamina (NADA)
  117. 2004

    Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension.

  118. 2004

    Transdermal Absorption of (-)-Linalool Induces Autonomic Deactivation but Has No Impact on Ratings of Well-Being in Humans

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)
  119. 2004

    Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Virodamina (O-AEA)
  120. 1999

    Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

    FavorávelEstudo em AnimaisDorDependência QuímicaDoenças Cardiovasculares (DCV)+2
  121. 1999

    Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

  122. 1980

    Effect of marihuana on intraocular and blood pressure in glaucoma.

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)GlaucomaTetraidrocanabinol (THC)
  123. 1979

    Effects of tetrahydrocannabinol on arterial and intraocular hypertension.

    FavorávelEnsaio ClínicoDoenças Cardiovasculares (DCV)Glaucoma
  124. 1978

    Toward drugs derived from Cannabis

  125. 1977

    A cannabinoid with cardiovascular activity but no overt behavioral effects

Continue por aqui

Perguntas frequentes

Quantos estudos sobre hipertensão arterial estão indexados no acervo?
São 125 estudos, publicados entre 1977 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 49 · Estudo em Animais: 31 · Ensaio Clínico: 23 · Ensaio Clínico Duplo-Cego: 16 · Estudo Laboratorial: 5 · Metanálise Clínica: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 86 favoráveis, 14 inconclusivos e 25 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Hipertensão Arterial — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/hipertensao-arterial/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Hipertensão Arterial — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/hipertensao-arterial/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.